
CAS 1148113-53-4
:Trier par
Degré de pureté (%)
0
100
|
0
|
50
|
90
|
95
|
100
6 produits concernés.
Aprepitant Related Compound A (3-[[(2R,3R)-2-[(R)-1-[3,5-Bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)morpholino]methyl]-1H-1,2,4-triazol-5(4H)-one)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C23H21F7N4O3Couleur et forme :White Off-White PowderMasse moléculaire :534.15019(R,R,R)-Aprepitant
CAS :Formule :C23H21F7N4O3Degré de pureté :95%Couleur et forme :SolidMasse moléculaire :534.4267Aprepitant USP Related Compound A ((1R,2R,3R)-Aprepitant)
CAS :Formule :C23H21F7N4O3Couleur et forme :White To Off-White SolidMasse moléculaire :534.433-[[(2R,3R)-2-[(R)-1-[3,5-Bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)morpholino]methyl]-1H-1,2,4-triazol-5(4H)-one ((R,R,R)-Aprepitant)
CAS :Produit contrôléFormule :C23H21F7N4O3Couleur et forme :NeatMasse moléculaire :534.43(R,R,R)-Aprepitant
CAS :Aprepitant is a neurokinin-1 receptor antagonist. It is an antiemetic which suppresses nausea and vomiting and has proven to be especially useful alongside cancer chemotherapy and as a tool in cancer-related studies. Aprepitant binds to the neurokinin-1 receptor in the brain, preventing it from binding to substance P. This prevents substance P from stimulating nerves in the vomiting center of the brain, reducing feelings of nausea and vomiting. Aprepitant has been shown to be effective against HIV infection, with no major side effects. The use of aprepitant for HIV therapy may be limited due to its ability to cause serious liver damage when taken with other drugs that are metabolized by cytochrome P450 enzymes.Formule :C23H21F7N4O3Degré de pureté :Min. 95%Masse moléculaire :534.43 g/mol






